These findings provide new insights into the molecular mechanisms by which obesity worsens lung injury and suggest that targeting the GFI1‐ACOD1 pathway could offer potential avenues for further investigation into therapeutic strategies for obesity‐related lung complications. This evidence concerns the gene GFI1 and obesity due to melanocortin 4 receptor deficiency.